
Faldaprevir
CAS No. 801283-95-4
Faldaprevir( BI 201335 | BI201335 | BI-201335 )
Catalog No. M15999 CAS No. 801283-95-4
A potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameFaldaprevir
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively.
-
DescriptionA potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively; also shows Ki of 2 to 230 nM for HCV GT2 to 6, potently inhibits HCV RNA replication in vitro of 6.5 and 3.1 nM in genotype 1a and 1b replicon assays, respectively; possesses good ADME profile in vitro and pharmacokinetics in vivo.HCV Infection Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsBI 201335 | BI201335 | BI-201335
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorHCV
-
Research AreaInfection
-
IndicationHCV Infection
Chemical Information
-
CAS Number801283-95-4
-
Formula Weight869.829
-
Molecular FormulaC40H49BrN6O9S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C([C@]1(NC([C@H]2N(C([C@@H](NC(OC3CCCC3)=O)C(C)(C)C)=O)C[C@H](OC4=CC(C5=CSC(NC(C(C)C)=O)=N5)=NC6=C(Br)C(OC)=CC=C46)C2)=O)[C@H](C=C)C1)O
-
Chemical Name(1R,2S)-1-[[(2S,4R)-4-[8-bromo-7-methoxy-2-[2-(2-methylpropanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-1-[(2S)-2-(cyclopentyloxycarbonylamino)-3,3-dimethylbutanoyl]pyrrolidine-2-carbonyl]amino]-2 ethenylcyclopropane-1-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Llinàs-Brunet M, et al. J Med Chem. 2010 Sep 9;53(17):6466-76.
2. White PW, et al. Antimicrob Agents Chemother. 2010 Nov;54(11):4611-8.
3. Manns MP, et al. J Hepatol. 2011 Jun;54(6):1114-22.
4. Zeuzem S, et al. Gastroenterology. 2011 Dec;141(6):2047-55; quiz e14.
molnova catalog



related products
-
Coblopasvir dihydroc...
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor.
-
Voxilaprevir
Voxilaprevir (GS-9857)?is a potent HCV NS3/4A protease inhibitor that is used in combination with sofosbuvir and velpatasvir for treatment of HCV infection.
-
U18666A
U18666A is a cell-permeable drug and is a cholesterol synthesis and transport inhibitor. It inhibits replication of Ebola virus, dengue virus, and human hepatitis C virus.